The effectiveness of current anti-clotting medication can be limited due to the risk of complications. This is driving a need for alternatives that can both prevent the formation of blood clots and reduce the risk of excessive and life-threatening bleeding. A new biocompatible lab-on-a-chip could help accelerate the discovery and development of new anti-clotting therapies, with automated processes that can achieve in a few minutes what could take days in a full-sized lab.
Click here for original story, Lab-on-a-chip drives search for new drugs to prevent blood clots
Source: ScienceDaily